Tag Archives:lymphoma
二甲双胍改善胰腺癌和lymphoma outcomes in DM2 patients
Type 2 diabetics are at increased risk of cancer in part because of increased insulin in the blood from insulin resistance. Insulin and its related growth factor IGF-1 can stimulate cell growth through the Ras-Raf-MEK-ERK or the
Routine imaging in patients with follicular lymphoma in remission
B-cell lymphomas are a heterogeneous group of malignancies originating from B lymphocytes. Modern day chemotherapy is effective in inducing disease remission in a large percentage of patients for most of the subtypes. Some of these subtypes, the
Can the heart get cancer? Quite rare, but yes
To many, the heart seems as an unusual location for cancer. In fact, most tumors that affect the heart are metastatic in origin (start in other organs and disseminate to the heart). Primary cardiac tumors (tumors that
What it takes to survive a transplant
Many patients with blood cancers, such as multiple myeloma, leukemia, or lymphoma, have radiation treatment or chemotherapy to destroy their tumor cells and diseased bone marrow. Unfortunately the treatment damages their immune system leaving them immunocompromised. To
The importance of clinical endpoints in lymphoma
Lymphomas, or neoplasms of the lymphoid system, include a broad array of cancers. The least aggressive, often called indolent, lymphomas (the most frequent of which is follicular lymphoma, FL) are characterized by their incurability. At the same
MYD88 mutation is associated with an unfavorable outcome of Primary Diffuse Large B-cell Lymphoma
Malignant lymphoma is a cancer of lymphocytes. This is actually a disease group consisting of multiple subtypes, among which diffuse large B-cell lymphoma (DLBCL) is characterized by diffuse proliferation of large B lymphoid cells. Primary DLBCL of
Defining optimal therapy for patients with aggressive B-cell lymphoma and central nervous system involvement
Aggressive lymphomas constitute a heterogeneous group of malignancies characterized by a fast growth and dissemination that exhibit a high sensitivity to chemotherapy , radiotherapy and immunotherapy , and show high cure rates with modern therapies . A
CD164 helps physicians to diagnose and treat cancer in Sézary Syndrome
Cutaneous T-cell lymphomas (CTCL) represent malignancies of the T-lymphocytes that go to or reside in the skin. Roughly 50% of all CTCL cases are Sézary Syndrome and Mycosis Fungoides. The typical external manifestation of the disease is
Dogs with lymphoma have better therapeutic responses and longer lifespans if they revealed lower white blood cell count after chemotherapy
Chemotherapy is effective against rapidly growing neoplasm. Chemotherapeutic drugs also damage other rapidly dividing cells, such as bone marrow stem cells. Because white blood cells have the shortest life spans in the hemocyte, bone marrow suppression commonly
Helpful tool for the characterization of cancer
Follicular lymphoma is a sort of blood cancer and among the most frequent subtypes of indolent (painless) lymphomas. Most patients are diagnosed very late, when the illness is in an advanced stage. The origins of the tumor
